in controlled assays of in vitro cmc , lymphocytes from melanoma patients ( 14/44 ) exhibited selective cytotoxicity ( destruction of only one target-cell type ) against the melanoma target cells , whereas only 3/97 control lymphocytes ( other malignancies and normal donors ) showed such melanoma-selective cytotoxicity .
C0006826
malignancies
C0025202
melanoma